Lunch & Learn

Innovations for Improved Robustness and Performance in Biomanufacturing for Cell and Gene Therapy

May 11, 2026​ | Cambridge, MA, USA


Overview

Join us for an insightful Lunch and Learn focusing on innovative biopharma solutions, including advancements in cell and gene therapy applications. This event is designed for professionals in the biopharmaceutical industry to explore advancements in cell culture ingredients and technology to enhance their understanding of bioprocess optimization.

Why Attend?

This is a unique opportunity to learn from industry experts, engage in valuable discussions, and connect with peers who are shaping the future of biopharma.


Key learnings for participants

  • Innovative Approaches: Learn about advancements in cell culture and media development for improved efficiency.
  • New Product Launches: Explore cutting-edge products shaping the future of biopharma.
  • Networking Opportunities: Connect with industry leaders and peers to foster collaboration.
  • Interactive Discussions: Address key challenges and future directions in biopharma.




Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.


Details
Participation fee: Free of charge 
Workshop language: English



Agenda
The workshop will start at 12 p.m. on Monday, May 11, 2026, and finish at 2:10 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The workshop will take place at:
238 Main Street, Cambridge, MA (located at Kendall/M.I.T. MBTA stop) 
United States of America

Fill out the form to register for the workshop:

Agenda

12:00 pm | Registration & Lunch

12:30 pm | Welcome Introduction
Jessica Young
Director, Business Development & Account Management
Evonik Health Care

12:35 pm | Viral and Non‑Viral Gene Delivery Strategies for Gene‑Modified T Cells
Dr. Cassie-Marie Peigné
Manager of Field Application Specialists NA / Advanced Therapy Solutions
Sartorius

1:05 pm | Reduced ingredient variability with chemically-defined and animal-free sustainable solutions
Zach Demorest
Director, Biopharma Solutions
Evonik Health Care

1:25 pm | Break

1:35 pm | Enhancing AAV Vector Production Through Multidimensional Process Optimization
Zhe Zhang
Associate Director
Regeneron

2:05 pm | Concluding Remarks
Jianfa Ou
Principal Scientist
Evonik Health Care

2:10 pm | Networking & Departure



​
Disclaimer
Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.



QUESTIONS? 

Likhitha Bingham
Marketing Analyst
+1 256-783-9347

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register